All Type 2 diabetes articles
-
SupplementGuideline for the managed introduction of biosimilar basal insulin
Guidelines identified a need for clinical guidance in a specific area and approached Mylan for an educational grant to support the development of a working party guideline. This working party guideline was developed by Guidelines , and the Chair and members of the group were chosen by and convened ...
-
Test and reflect
Collaborative stakeholder initiative for the management of type 2 diabetes in older people
This CPD activity consists of 3 multiple-choice questions (MCQs) designed to test your knowledge on the management of diabetes in older people, including in the context of frailty.
-
Formulary decision guide
Formulary decision guide: Ozempic®▼ (semaglutide)
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice . It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide. Download the formulary decision guide ...
-
Supplement
Management of Type 2 Diabetes and Cardiovascular Disease
Information intended for healthcare professionals only. This supplement has been commissioned and funded by Boehringer Ingelheim Limited and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice . Please see the bottom of the page for full disclaimer. View prescribing information Download ...
-
Digital edition
May 2019 issue
The digital edition of the May 2019 issue of Guidelines in Practice , featuring articles on: type 2 diabetes, fetal alcohol spectrum disorder, sexually transmitted infections, and GP appraisal tips.
-
Implementing guidelines
Type 2 diabetes: targets and treatments should be person-centred
Dr Clare Hambling and Dr Patrick Holmes highlight the key recommendations from the joint ADA/EASD consensus report on the management of hyperglycaemia in type 2 diabetes
-
Checklist
Implementing the ADA and EASD 2018 consensus report: management of hyperglycaemia in type 2 diabetes
Information intended for healthcare professionals only. This checklist has been commissioned and funded by Boehringer Ingelheim Limited and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice . Please see the bottom of the page for full disclaimer. View prescribing information If the PDF does not ...
-
Formulary decision guide
Jardiance® (empagliflozin) film-coated tablets
This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice. View prescribing information Key points on this medicine Jardiance: is a once-daily SGLT2 inhibitor that improves ...
-
Animation
Management of hyperglycaemia in type 2 diabetes, 2018: ADA/EASD consensus report
Watch this short animation, commissioned by Napp Pharmaceuticals Limited, to find out about the third joint consensus report on the management of hyperglycaemia in type 2 diabetes by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
-
Digital edition
February 2019 issue
The digital edition of the February 2019 issue of Guidelines in Practice , featuring articles on: COPD, covert medication, type 2 diabetes, and talking about weight with patients.
-
Pharmacist focus
Type 2 diabetes: the role of the practice pharmacist
Muhammad Siddiqur Rahman highlights the integral role of practice-based pharmacists in managing type 2 diabetes
-
Formulary decision guide
Semglee® ▼ (insulin glargine biosimilar)
This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice .
-
Test and reflect
Best practice in managing co-morbidities in type 2 diabetes
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on managing the co-morbidities of type 2 diabetes—you will then be prompted to reflect on your learning.
-
Co-morbidities in ...
Co-morbidities in type 2 diabetes
Dr Kevin Fernando describes eight common co-morbidities in patients with type 2 diabetes and how the co-existing conditions should be managed
-
Test and reflect
SIGN guideline on pharmacological management of type 2 diabetes
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on SIGN guideline recommendations on managing type 2 diabetes—you will then be prompted to reflect on your learning.
-
Implementing guidelines
Type 2 diabetes: what are the benefits and risks of glucose-lowering agents?
Dr Kevin Fernando explains how SIGN 154 offers evidence-based guidance on glucose control therapies for people with type 2 diabetes
-
News
SIGN updates diabetes guidance
The Scottish Intercollegiate Guidelines Network has updated its guidance on the management of diabetes and published new guidance on pharmacological management of glycaemic control in people with type 2 diabetes.
-
Test and reflect
NICE guideline on type 2 diabetes
This CPD activity consists of 4 multiple-choice questions (MCQs) designed to test your knowledge on type 2 diabetes in adults—you will then be prompted to reflect on your learning.
-
News
NICE updates guidance on type 2 diabetes prevention
NICE has published an update to NICE Public Health Guideline 38 on Type 2 diabetes: prevention in people at high risk.
-
Top tips
Top tips: type 2 diabetes
Dr Kevin Fernando provides top tips on diagnosing and managing type 2 diabetes and identifying people at high risk
